FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

4765811000001108: Tracleer 125mg tablets (Janssen-Cilag Ltd) 56 tablet 4 x 14 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1390361000001115 Tracleer 125mg tablets (Janssen-Cilag Ltd) 56 tablet 4 x 14 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1390371000001113 Tracleer 125mg tablets (Janssen-Cilag Ltd) 56 tablet 4 x 14 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tracleer 125mg tablets (Janssen-Cilag Ltd) 56 tablet 4 x 14 tablets Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Tracleer 125mg tablets (Janssen-Cilag Ltd) 56 tablet 4 x 14 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Tracleer 125mg tablets (Janssen-Cilag Ltd) 56 tablet 4 x 14 tablets Is a Bosentan 125mg tablets 56 tablet true Inferred relationship Existential restriction modifier
Tracleer 125mg tablets (Janssen-Cilag Ltd) 56 tablet 4 x 14 tablets Is pack of Tracleer 125mg tablets (Janssen-Cilag Ltd) false Inferred relationship Existential restriction modifier
Tracleer 125mg tablets (Janssen-Cilag Ltd) 56 tablet 4 x 14 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Tracleer 125mg tablets (Janssen-Cilag Ltd) 56 tablet 4 x 14 tablets Has active ingredient Bosentan false Inferred relationship Existential restriction modifier
Tracleer 125mg tablets (Janssen-Cilag Ltd) 56 tablet 4 x 14 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Tracleer 125mg tablets (Janssen-Cilag Ltd) 56 tablet 4 x 14 tablets Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Tracleer 125mg tablets (Janssen-Cilag Ltd) 56 tablet 4 x 14 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Tracleer 125mg tablets (Janssen-Cilag Ltd) 56 tablet 4 x 14 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Tracleer 125mg tablets (Janssen-Cilag Ltd) 56 tablet 4 x 14 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Tracleer 125mg tablets (Janssen-Cilag Ltd) 56 tablet 4 x 14 tablets Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Tracleer 125mg tablets (Janssen-Cilag Ltd) 56 tablet 4 x 14 tablets Has AMP Tracleer 125mg tablets (Janssen-Cilag Ltd) true Inferred relationship Existential restriction modifier
Tracleer 125mg tablets (Janssen-Cilag Ltd) 56 tablet 4 x 14 tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Bosentan true Inferred relationship Existential restriction modifier
Tracleer 125mg tablets (Janssen-Cilag Ltd) 56 tablet 4 x 14 tablets Has specific active ingredient Bosentan monohydrate false Inferred relationship Existential restriction modifier
Tracleer 125mg tablets (Janssen-Cilag Ltd) 56 tablet 4 x 14 tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Tracleer 125mg tablets (Janssen-Cilag Ltd) 56 tablet 4 x 14 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Tracleer 125mg tablets (Janssen-Cilag Ltd) 56 tablet 4 x 14 tablets Has specific active ingredient Bosentan monohydrate true Inferred relationship Existential restriction modifier
Tracleer 125mg tablets (Janssen-Cilag Ltd) 56 tablet 4 x 14 tablets Has basis of strength substance Bosentan true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start